Effects of an energy-restricted diet rich in plant-derived α-linolenic acid on systemic inflammation and endothelial function in overweight-to-obese patients with metabolic syndrome traits.
Study Goal
The researchers aimed to determine whether a hypoenergetic diet rich in ALA (3.4 g/d) improves biomarkers of systemic inflammation and vascular function compared to a low-ALA diet (0.9 g/d) in overweight-to-obese patients with metabolic syndrome traits.
Results Summary
Both diets led to significant reductions in inflammatory and vascular biomarkers, but the high-ALA diet showed a more pronounced reduction in YKL-40 compared to the low-ALA diet. No inter-group differences were observed for other biomarkers, though improvements correlated with body fat loss.
Population
Overweight-to-obese patients with metabolic syndrome traits (n=81).
Effective Dosage
3.4 g/d (high-ALA diet) vs. 0.9 g/d (low-ALA diet).
Duration
6 months.
Interactions
None mentioned.
| Intervention | Direction | Endpoint | Population | Dosage | Impact | Claim # |
|---|---|---|---|---|---|---|
Plant-derived α-linolenic acid (ALA) | decrease | risk of CVD | - | - | may reduce | #1 |
Plant-derived α-linolenic acid (ALA) | decrease | systemic inflammation | - | - | possibly by decreasing | #2 |
Plant-derived α-linolenic acid (ALA) | increase | endothelial function | - | - | improving | #3 |
hypoenergetic diet rich in ALA (3·4 g/d) | decrease | serum concentrations of C-reactive protein (CRP) | eighty-one overweight-to-obese patients with metabolic syndrome traits | - | significant decreases | #4 |
hypoenergetic diet rich in ALA (3·4 g/d) | decrease | serum concentrations of TNF-α | eighty-one overweight-to-obese patients with metabolic syndrome traits | - | significant decreases | #5 |
hypoenergetic diet rich in ALA (3·4 g/d) | decrease | serum concentrations of IL-6 | eighty-one overweight-to-obese patients with metabolic syndrome traits | - | significant decreases | #6 |
hypoenergetic diet rich in ALA (3·4 g/d) | decrease | serum concentrations of soluble intercellular adhesion molecule-1 (sICAM-1) | eighty-one overweight-to-obese patients with metabolic syndrome traits | - | significant decreases | #7 |
hypoenergetic diet rich in ALA (3·4 g/d) | decrease | serum concentrations of soluble endothelial selectin (sE-selectin) | eighty-one overweight-to-obese patients with metabolic syndrome traits | - | significant decreases | #8 |
hypoenergetic diet rich in ALA (3·4 g/d) | decrease | serum concentrations of asymmetric dimethylarginine | eighty-one overweight-to-obese patients with metabolic syndrome traits | - | significant decreases | #9 |
hypoenergetic diet low in ALA (0·9 g/d, control) | decrease | serum concentrations of C-reactive protein (CRP) | eighty-one overweight-to-obese patients with metabolic syndrome traits | - | significant decreases | #10 |
hypoenergetic diet low in ALA (0·9 g/d, control) | decrease | serum concentrations of TNF-α | eighty-one overweight-to-obese patients with metabolic syndrome traits | - | significant decreases | #11 |
hypoenergetic diet low in ALA (0·9 g/d, control) | decrease | serum concentrations of IL-6 | eighty-one overweight-to-obese patients with metabolic syndrome traits | - | significant decreases | #12 |
hypoenergetic diet low in ALA (0·9 g/d, control) | decrease | serum concentrations of soluble intercellular adhesion molecule-1 (sICAM-1) | eighty-one overweight-to-obese patients with metabolic syndrome traits | - | significant decreases | #13 |
hypoenergetic diet low in ALA (0·9 g/d, control) | decrease | serum concentrations of soluble endothelial selectin (sE-selectin) | eighty-one overweight-to-obese patients with metabolic syndrome traits | - | significant decreases | #14 |
hypoenergetic diet low in ALA (0·9 g/d, control) | decrease | serum concentrations of asymmetric dimethylarginine | eighty-one overweight-to-obese patients with metabolic syndrome traits | - | significant decreases | #15 |
hypoenergetic diet rich in ALA (3·4 g/d) | no change | serum concentrations of C-reactive protein (CRP), TNF-α, IL-6, soluble intercellular adhesion molecule-1 (sICAM-1), soluble endothelial selectin (sE-selectin) and asymmetric dimethylarginine | eighty-one overweight-to-obese patients with metabolic syndrome traits | - | no inter-group differences were observed | #16 |
hypoenergetic diet rich in ALA (3·4 g/d) | decrease | serum concentration of YKL-40 (human cartilage glycoprotein 39 or chitinase-3-like protein 1) | eighty-one overweight-to-obese patients with metabolic syndrome traits | - | decreased | #17 |
hypoenergetic diet rich in ALA (3·4 g/d) | no change | plasma concentrations of fibrinogen | eighty-one overweight-to-obese patients with metabolic syndrome traits | - | did not significantly change | #18 |
hypoenergetic diet low in ALA (0·9 g/d, control) | no change | plasma concentrations of fibrinogen | eighty-one overweight-to-obese patients with metabolic syndrome traits | - | did not significantly change | #19 |
hypoenergetic diet rich in ALA (3·4 g/d) | decrease | serum concentrations of sICAM-1, sE-selectin, CRP and YKL-40 | eighty-one overweight-to-obese patients with metabolic syndrome traits | - | decreases were significantly correlated with the decreases | #20 |
hypoenergetic diet rich in ALA (3·4 g/d) | decrease | body fat mass | eighty-one overweight-to-obese patients with metabolic syndrome traits | - | decreases were significantly correlated with the decreases | #21 |
body-weight loss | increase | vascular function | overweight-to-obese patients with metabolic syndrome traits | - | improved | #22 |
body-weight loss | decrease | inflammation | overweight-to-obese patients with metabolic syndrome traits | - | improved | #23 |
high ALA intake | decrease | serum concentration of YKL-40 | overweight-to-obese patients with metabolic syndrome traits | - | led to a more pronounced reduction | #24 |
Plant-derived α-linolenic acid (ALA) may reduce the risk of CVD, possibly by decreasing systemic inflammation and improving endothelial function. In the present study, the effects of a hypoenergetic diet rich in ALA (3·4 g/d) on the biomarkers of systemic inflammation and vascular function were investigated in eighty-one overweight-to-obese patients with metabolic syndrome traits in comparison with a hypoenergetic diet low in ALA (0·9 g/d, control). After a 6-month dietary intervention, there were significant decreases in the serum concentrations of C-reactive protein (CRP), TNF-α, IL-6, soluble intercellular adhesion molecule-1 (sICAM-1), soluble endothelial selectin (sE-selectin) and asymmetric dimethylarginine in both dietary groups. However, no inter-group differences were observed for all these changes. The serum concentration of YKL-40 (human cartilage glycoprotein 39 or chitinase-3-like protein 1) decreased after the ALA diet when compared with the control diet (P< 0·05 for time × treatment interaction). Plasma concentrations of fibrinogen did not significantly change in the two dietary groups. The decreases in the serum concentrations of sICAM-1, sE-selectin, CRP and YKL-40 were significantly correlated with the decreases in body fat mass. In conclusion, the present study indicates that in overweight-to-obese patients with metabolic syndrome traits, both vascular function and inflammation are improved during body-weight loss. The high ALA intake led to a more pronounced reduction in the serum concentration of YKL-40 compared with the intake of the low-ALA control diet, indicating the existence of independent favourable physiological effects of ALA during weight loss.